Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $24.28 -1.18%
Revenue Growth %: -23.8%
Financial Fact:
Basic (in Shares): -23.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -23.8%
Financial Fact:
Basic (in Shares): -23.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.32), $0.06 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $47.8 million versus the consensus estimate of $49.05 million.
GUIDANCE:
Adaptive Biotechnologies sees FY2022 revenue of $185-190 million, versus the consensus of $187.5 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance
- Torrid Holdings Inc. (CURV) Tops Q2 EPS by 8c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
